Literature DB >> 6978966

Logistics of tumor immunology.

H Kirchner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978966     DOI: 10.1007/BF01721586

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  50 in total

1.  The Epstein-Barr virus.

Authors:  W Henle; G Henle; E T Lennette
Journal:  Sci Am       Date:  1979-07       Impact factor: 2.142

2.  High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus.

Authors:  W F Jarrett; P E McNeil; W T Grimshaw; I E Selman; W I McIntyre
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

3.  The Epstein-Barr virus and neoplasia.

Authors:  G Klein
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

4.  Immunotherapy of cancer in animals: models or muddles?

Authors:  G L Bartlett; J W Kreider; D M Purnell
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

5.  Back to the drawing board--the need for more realistic model systems for immunotherapy.

Authors:  P Alexander
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

Review 6.  The origin and development of human tumors studied with cell markers.

Authors:  P J Fialkow
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

Review 7.  T cell control of antibody production.

Authors:  R K Gershon
Journal:  Contemp Top Immunobiol       Date:  1974

Review 8.  Nonimmunological host defenses: a review.

Authors:  C A Apffel
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

9.  The specificity of concomitant tumor immunity at large tumor volumes.

Authors:  P J Deckers; D H Pardridge; B S Wang; J A Mannick
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

10.  Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.

Authors:  J R Oehler; L R Lindsay; M E Nunn; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.